Exosomal microRNA-122 mediates obesity-related cardiomyopathy through suppressing mitochondrial ADP-ribosylation factor-like 2
- 10 September 2019
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 133 (17) , 1871-1881
Abstract
Emerging studies have demonstrated that microRNAs (miRs) participate in the development of multiple metabolic complications including cardiovascular diseases. Among them, circulating level of liver-secreted miR-122 was closely correlated with several consequence of heart diseases in clinical studies, and overexpression of miR-122 impaired cardiomyocyte function. However, it was unknown whether miR-122 could regulate cardiac biology in obesity. Therefore, present study was to disclose the role of miR-122 in cardiac metabolic disorders and potential molecular mechanisms. Through utilizing clinical samples and high fat diet-fed mice, we investigated the physiological roles of miR-122 in obesity-related cardiomyopathy. Besides, present study explored the mitochondrial function under exosomal miR-122 stimulation in mouse primary cardiomyocytes. In clinical samples and obese mice, the circulating level of exosomal miR-122 was positively correlated with cardiac dysfunctional parameters, including reduction in ejection fraction (EF) and increased levels of NT-proBNP. Human plasma exosomes transported miR-122 into mouse primary cardiomyocytes, and impaired mitochondrial ATP production and oxygen consumption, whereas miR-122 sponge improved these inhibitory effects. In dietary-induced mice, increased hepatic and circulating exosomal miR-122 deteriorated cardiac structure and functional index, and inhibited mitochondrial function. Liver-specific blockage of miR-122 attenuated abnormal cardiac remodeling. Mechanistically, miR-122 directly bound and suppressed mitochondrial protein ADP-ribosylation factor-like 2 (Arl-2) in vitro and in vivo. Knockdown of Arl-2 abolished the mitochondrial benefits of miR-122 sponge in exosome-treated mouse primary cardiomyocytes. In conclusions, our present study firstly showed that liver-secreted exosomal miR-122 played a critical role in the development of metabolic cardiomyopathy, and miR-122/mitochondrial Arl-2 signaling affected cardiac energy homeostasis.Keywords
This publication has 32 references indexed in Scilit:
- Exosomal microRNA-29a mediates cardiac dysfunction and mitochondrial inactivity in obesity-related cardiomyopathyEndocrine, 2018
- Exosomal microRNA-194 causes cardiac injury and mitochondrial dysfunction in obese miceBiochemical and Biophysical Research Communications, 2018
- Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafishBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2018
- MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXRBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin SensitivityCell, 2017
- Mitochondrial dysfunction and its impact on diabetic heartBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Mitochondrial dysfunction and oxidative stress in metabolic disorders — A step towards mitochondria based therapeutic strategiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Cardiac Lipotoxicity: Molecular Pathways and Therapeutic ImplicationsCurrent Heart Failure Reports, 2013
- miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingCell Metabolism, 2006
- Application of NT-proBNP and BNP Measurements in Cardiac Care: A More Discerning Marker for the Detection and Evaluation of Heart FailureEuropean Journal of Heart Failure, 2004